Thermo Fisher Scientific (Finance I) B.V. is a financial subsidiary of Thermo Fisher Scientific, founded to support its global operations by managing financing needs from its base in the Netherlands. The company provides essential services that include financial management and investment strategies tailored to the broader scientific and life sciences industries, enhancing the parent company's capacity for innovation and research.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| TMO 0.00% 2025-11-18 EURThermo Fisher Scientific (Finance I) B.V. | Netherlands | 2025-11-18 | 0.000 | 0.00 |
| TMO 0.80% 2030-10-18 EURThermo Fisher Scientific (Finance I) B.V. | United States | 2030-10-18 | 0.800 | 2.84 |
| TMO 1.13% 2033-10-18 EURThermo Fisher Scientific (Finance I) B.V. | United States | 2033-10-18 | 1.125 | 3.23 |
| TMO 1.63% 2041-10-18 EURThermo Fisher Scientific (Finance I) B.V. | United States | 2041-10-18 | 1.625 | 4.02 |
| TMO 2.00% 2051-10-18 EURThermo Fisher Scientific (Finance I) B.V. | United States | 2051-10-18 | 2.000 | 4.35 |
| TMO 3.63% 2035-12-01 EURThermo Fisher Scientific (Finance I) B.V. | United States | 2035-12-01 | 3.628 | 3.56 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Thermo Fisher Scientific (Finance I) B.V. has issued bonds to facilitate capital raising and operational support. Notably, the company began its bond issuance program in 2014, significantly expanding its financing capabilities with a prominent $1 billion issuance in 2020, which was used to fund acquisitions and repay existing debt. Current yields on its bonds are competitive within the industry, reflecting investor confidence and robust financial performance, with notable features such as callable options and fixed-rate returns that cater to retail investors seeking stable income.